Disease severity and family history in keratoconus
- L Szczotka-Flynn1,
- M Slaughter2,
- T McMahon3,
- J Barr4,
- T Edrington5,
- B Fink4,
- J Lass1,
- M Belin6,
- S K Iyengar2,
- CLEK Study Group
- 1Department of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH, USA
- 2Department of Epidemiology and Biostatistics, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH, USA
- 3Department of Ophthalmology & Visual Sciences University of Illinois-Chicago, Chicago, IL, USA
- 4The Ohio State University School of Optometry, Columbus, OH, USA
- 5Southern California College of Optometry, Fullerton, CA, USA
- 6Albany Medical College, Albany, NY, USA
- Dr L Szczotka-Flynn, Department of Ophthalmology and Visual Sciences, Case Western Reserve University, 11100 Euclid Ave., Bolwell Bldg. Suite 3200, Cleveland, OH 44106, USA; loretta.szczotka{at}uhhospitals.org
- Accepted 26 April 2008
Abstract
Background/aims: To determine if disease severity is associated with a family history of keratoconus.
Methods: Markers of disease severity in the CLEK Study cohort were assessed to determine if they could discriminate individuals with and without family history. Logistic regression was used to examine association between corneal scarring, average corneal power, flat and steep keratometry readings, and higher-order root mean square (RMS) wavefront error with family history.
Results: In univariate analyses, none of the severity indices had any significant associations with family history; however, contact lens use, gender, and Caucasian race were found to be significant predictors. After controlling for these confounders, there were no significant associations between any severity indices and family history.
Conclusions: Presence or absence of family history is not associated with more severe clinical disease, at least when each marker for severity is considered independently. The results of this analysis are important for genetic studies of keratoconus in that it will allow recruitment of keratoconus patients across all stages of disease severity because it does not influence familial aggregation.
Footnotes
-
Funding: Supported by National Eye Institute Grants R21 EY015145 (JL); EY10419, EY10069, EY10077, EY02687, EY12656 (CLEK); RO3EY17571 (TM); Research to Prevent Blindness (JL); American Optometric Foundation (LSF); and Ohio Lion’s Eye Research Foundation (LSF, JL).
-
Competing interests: Since the original submission of this manuscript, JB is now an employee of Bausch & Lomb; MB is a consultant to Oculus USA. Other authors: none.
-
Ethics approval: Ethics approval was obtained.
-
Patient consent: Obtained.
